Leerink Swann Starts Nabi Biopharmaceuticals (NABI) at Outperform; NicVAX a Potential Blockbuster Rising from the Ashes
Go back to Leerink Swann Starts Nabi Biopharmaceuticals (NABI) at Outperform; NicVAX a Potential Blockbuster Rising from the Ashes| Nabi Biopharmaceuticals (NASDAQ: NABI) | Delayed: 1.80 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.80 | 52 Week High | $2.03 | |||
| Open | $15.41 | 52 Week Low | $1.53 | |||
| Day High | $1.80 | P/E | N/A | |||
| Day Low | $1.80 | EPS | $-0.21 | |||
| Volume | 200 | |||||
